CDER New February 10, 2017

What's New on the FDA Drugs Site

February 9, 2017

• Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Ibuprofen Lysine Injection, 20 Mg/2 Ml (10 Mg/Ml) Due to Particulate Matter
• FDA approves Emflaza (deflazacort) to treat Duchenne muscular dystrophy
• FDA Drug Shortages
  • Epinephrine Injection, 0.1 mg/mL (Updated - Discontinuation)
  • Ranitidine Injection, USP (Updated - Currently in Shortage)
• La FDA advierte acerca de reacciones alérgicas poco comunes pero graves del antiséptico tópico con gluconato de clorhexidina